INP-05

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameINP-05
Drug Alias NameCNS drug (Impel NeuroPharma)INP-05
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionOpioid receptors modulators
TargetsOpioid receptors
Therapy Area/IndicationsPainParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImpel Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImpel Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsPainParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A